[go: up one dir, main page]

NO159090C - Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.

Info

Publication number
NO159090C
NO159090C NO820112A NO820112A NO159090C NO 159090 C NO159090 C NO 159090C NO 820112 A NO820112 A NO 820112A NO 820112 A NO820112 A NO 820112A NO 159090 C NO159090 C NO 159090C
Authority
NO
Norway
Prior art keywords
pyridoindol
derivatives
preparation
therapeutic active
analogue procedure
Prior art date
Application number
NO820112A
Other languages
English (en)
Norwegian (no)
Other versions
NO820112L (no
NO159090B (no
Inventor
Willard Mckowan Welch
Charles Armon Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO820112L publication Critical patent/NO820112L/no
Priority to NO871349A priority Critical patent/NO160443C/no
Publication of NO159090B publication Critical patent/NO159090B/no
Publication of NO159090C publication Critical patent/NO159090C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO820112A 1981-01-16 1982-01-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater. NO159090C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO871349A NO160443C (no) 1981-01-16 1987-03-31 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/225,569 US4337250A (en) 1979-07-30 1981-01-16 Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents

Publications (3)

Publication Number Publication Date
NO820112L NO820112L (no) 1982-07-19
NO159090B NO159090B (no) 1988-08-22
NO159090C true NO159090C (no) 1988-11-30

Family

ID=22845384

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820112A NO159090C (no) 1981-01-16 1982-01-15 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.

Country Status (27)

Country Link
US (1) US4337250A (sv)
EP (1) EP0060610B1 (sv)
JP (2) JPS57139078A (sv)
KR (1) KR860001819B1 (sv)
AR (1) AR230283A1 (sv)
AT (1) ATE15372T1 (sv)
AU (1) AU528710B2 (sv)
CA (1) CA1177830A (sv)
CS (1) CS248020B2 (sv)
DD (3) DD211348A5 (sv)
DE (1) DE3265922D1 (sv)
DK (1) DK15282A (sv)
EG (1) EG15796A (sv)
ES (11) ES8304966A1 (sv)
FI (1) FI71936C (sv)
GR (1) GR74757B (sv)
HU (1) HU189090B (sv)
IE (1) IE51954B1 (sv)
IL (1) IL64774A (sv)
NO (1) NO159090C (sv)
NZ (1) NZ199473A (sv)
PH (1) PH19614A (sv)
PL (2) PL138924B1 (sv)
PT (1) PT74283A (sv)
SU (2) SU1179930A3 (sv)
YU (1) YU45854B (sv)
ZA (1) ZA82264B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4732984A (en) * 1985-10-17 1988-03-22 American Home Products Corporation Piperazinoisothiazolones with psychotropic activity
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
JPH01140486A (ja) * 1987-11-27 1989-06-01 Hitachi Ltd ブロッホラインメモリ駆動回路
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
TW470745B (en) * 1996-05-23 2002-01-01 Janssen Pharmaceutica Nv Hexahydro-pyrido[4,3-b]indole derivatives
US5879444A (en) * 1997-09-02 1999-03-09 Bayer Corporation Organic pigment compositions
EP1414819B1 (en) 2001-08-08 2005-10-12 Pharmacia & Upjohn Company LLC THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (sv) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4252811A (en) * 1979-07-30 1981-02-24 Pfizer Inc. Hexahydro-trans-pyridoindole neuroleptic agents

Also Published As

Publication number Publication date
ES8401965A1 (es) 1984-01-01
ES518291A0 (es) 1984-06-16
ES518295A0 (es) 1984-01-01
JPS57139078A (en) 1982-08-27
YU9882A (en) 1986-04-30
FI71936C (sv) 1987-03-09
ES8401963A1 (es) 1984-01-01
ES8404851A1 (es) 1984-05-16
ES518294A0 (es) 1984-05-16
ES518296A0 (es) 1984-01-01
ES8401964A1 (es) 1984-01-01
FI820138L (fi) 1982-07-17
DK15282A (da) 1982-08-27
DD208980A5 (de) 1984-04-18
CS248020B2 (en) 1987-01-15
US4337250A (en) 1982-06-29
ES508809A0 (es) 1983-03-16
ES8401962A1 (es) 1984-01-01
PL137682B1 (en) 1986-07-31
ES518289A0 (es) 1984-05-16
AU528710B2 (en) 1983-05-12
GR74757B (sv) 1984-07-11
KR860001819B1 (ko) 1986-10-24
ATE15372T1 (de) 1985-09-15
ES8405002A1 (es) 1984-05-16
ES518292A0 (es) 1984-01-01
JPS6130674B2 (sv) 1986-07-15
ES518297A0 (es) 1984-06-01
EG15796A (en) 1986-12-30
SU1152522A3 (en) 1985-04-23
ES518293A0 (es) 1984-06-16
DE3265922D1 (en) 1985-10-10
ES518288A0 (es) 1984-01-01
PL138924B1 (en) 1986-11-29
IE820061L (en) 1982-07-16
EP0060610A1 (en) 1982-09-22
PH19614A (en) 1986-05-30
ES8405003A1 (es) 1984-05-16
PL235180A1 (en) 1983-11-21
AU7955282A (en) 1982-07-22
YU45854B (sh) 1992-09-07
ES8405391A1 (es) 1984-06-01
AR230283A1 (es) 1984-03-01
DD222027A5 (de) 1985-05-08
NZ199473A (en) 1985-10-11
IE51954B1 (en) 1987-04-29
IL64774A (en) 1985-06-30
ES8405617A1 (es) 1984-06-16
JPS60185780A (ja) 1985-09-21
ZA82264B (en) 1982-12-29
NO820112L (no) 1982-07-19
PT74283A (pt) 1982-02-01
ES8405785A1 (es) 1984-06-16
SU1179930A3 (ru) 1985-09-15
KR830009095A (ko) 1983-12-17
CA1177830A (en) 1984-11-13
ES518290A0 (es) 1984-05-16
IL64774A0 (en) 1982-03-31
NO159090B (no) 1988-08-22
FI71936B (fi) 1986-11-28
DD211348A5 (de) 1984-07-11
ES8304966A1 (es) 1983-03-16
EP0060610B1 (en) 1985-09-04
HU189090B (en) 1986-06-30
PL241179A1 (en) 1984-03-26

Similar Documents

Publication Publication Date Title
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO821085L (no) Fremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO820583L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(indolyl-piperidino-alkyl)-benzimidazolon-derivater.
NO158876C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO155771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO821882L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.